Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP before embryo transfer for recurrent pregnancy loss
IRCT20160722029027N9Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2017
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of platelet-rich plasma in recurrent miscarriage (RPL) and female infertility (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Pregnancy rate and Live birth rate. Started Apr 2017; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
recurrent miscarriage (RPL)female infertility
Beyond the preview
Go deeper on IRCT20160722029027N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160722029027N9.